SQUAMOUS CELL CARCINOMA OF UNKNOWN PRIMARY
Clinical trials for SQUAMOUS CELL CARCINOMA OF UNKNOWN PRIMARY explained in plain language.
Never miss a new study
Get alerted when new SQUAMOUS CELL CARCINOMA OF UNKNOWN PRIMARY trials appear
Sign up with your email to follow new studies for SQUAMOUS CELL CARCINOMA OF UNKNOWN PRIMARY, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Cancer-Fighting virus teams up with immunotherapy to tackle rare skin tumors
Disease control OngoingThis phase II trial is testing whether a combination of talimogene laherparepvec (a modified herpes virus that infects and kills cancer cells) and nivolumab (an immunotherapy drug) can shrink tumors in people with rare skin cancers or lymphomas that haven't responded to standard …
Matched conditions: SQUAMOUS CELL CARCINOMA OF UNKNOWN PRIMARY
Phase: PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Aug 15, 2026 00:00 UTC
-
Immunotherapy-Chemo cocktail shows promise in head and neck cancer trial
Disease control OngoingThis phase II trial is testing whether combining the immunotherapy drug cemiplimab with low doses of two chemotherapy drugs (paclitaxel and carboplatin) can shrink tumors in people with head and neck cancer that has come back or spread. The study includes 46 participants who have…
Matched conditions: SQUAMOUS CELL CARCINOMA OF UNKNOWN PRIMARY
Phase: PHASE2 • Sponsor: Marcelo Bonomi • Aim: Disease control
Last updated Jun 27, 2026 14:02 UTC